{
    "eid": "2-s2.0-85127065859",
    "title": "Consumers\u2019 adverse drug event reporting via community pharmacists: three stakeholder perception",
    "cover-date": "2022-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacy",
            "@code": "3611",
            "@abbrev": "HEAL"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology, Toxicology and Pharmaceutics (all)",
            "@code": "3000",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Health Policy",
            "@code": "2719",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Adverse drug event reporting",
        "Community pharmacists",
        "Consumers",
        "Pharmacovigilance center",
        "Stakeholder perception"
    ],
    "authors": [
        "Tanattha Kitisopee",
        "Jirunya Assanee",
        "Bernard A. Sorofman",
        "Suntaree Watcharadmrongkun"
    ],
    "citedby-count": 3,
    "ref-count": 24,
    "ref-list": [
        "Adverse drug reactions",
        "Pharmacovigilance: methods, recent developments and future perspectives",
        "Role of pharmacovigilance in India: An overview",
        "Adverse drug reaction reporting by community pharmacists\u2014the barriers and facilitators",
        "Community pharmacists\u2019 knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey",
        "Patterns of adverse drug reactions in different age groups: analysis of spontaneous reports by community pharmacists",
        "Adverse drug reactions reporting: Knowledge and opinion of general public in Penang, Malaysia",
        "Report: Problems of health products vigilance in drug stores",
        "How many interviews are enough? An experiment with data saturation and variability",
        "Community pharmacists\u2019 knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia",
        "Prevalence, determinants, and reasons for the non-reporting of adverse drug reactions by pharmacists in the Miyagi and Hokkaido regions of Japan",
        "Reporting adverse drug reactions: evaluation of knowledge, attitude and practice among community pharmacists in UAE",
        "Community pharmacists\u2019 attitudes towards adverse drug reaction reporting and their knowledge of the new pharmacovigilance legislation in the southern region of Portugal: a mixed methods study",
        "Community pharmacists\u2019 knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia",
        "Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region",
        "Are consumers ready to take part in the Pharmacovigilance System?\u2014a Portuguese preliminary study concerning ADR reporting",
        "Patients\u2019 motives for participating in active post-marketing surveillance",
        "Factors affecting patient reporting of adverse drug reactions: a systematic review",
        "Influence of pharmacists\u2019 attitudes on adverse drug reaction reporting"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Iowa City",
            "@id": "60024324",
            "affilname": "University of Iowa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024324",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Chulalongkorn University"
    ]
}